“Cost Saving and Predictive Factors of Response to Rituximab in Rheumatoid Arthritis, Including the IL-6 Promoter Gene Polymorphism”. Italian Journal of Public Health, vol. 9, no. 4, Oct. 2012, https://doi.org/10.2427/8696.